Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Koopman-Keemink

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 20, 2018
[A boy with involuntary movements]G M Kalisvaart, Y Koopman-Keemink
Annals of the Rheumatic Diseases|April 17, 2008
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national registerF H M Prince, M Twilt, R ten Cate, et al.
Rheumatology (Oxford, England)|July 18, 2008
Development of a web-based register for the Dutch national study on biologicals in JIA: www.ABC-register.nlF H M Prince, I S Ferket, S Kamphuis, et al.
Annals of the Rheumatic Diseases|June 16, 2009
When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritisF H M Prince, M Twilt, S C M Simon, et al.
Annals of the Rheumatic Diseases|July 8, 2009
Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritisF H M Prince, L M Geerdink, G J J M Borsboom, et al.
Pediatric Rheumatology Online Journal|February 8, 2017
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-studyP C E Hissink Muller, D M C Brinkman, D Schonenberg, et al.
Pediatric Rheumatology Online Journal|September 6, 2019
No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritisP C E Hissink Muller, W G van Braak, D Schreurs, et al.
Annals of the Rheumatic Diseases|July 23, 2013
Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patientsP C E Hissink Muller, J Anink, J Shi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|January 20, 2018
[A boy with involuntary movements]G M Kalisvaart, Y Koopman-Keemink
Annals of the Rheumatic Diseases|April 17, 2008
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national registerF H M Prince, M Twilt, R ten Cate, et al.
Rheumatology (Oxford, England)|July 18, 2008
Development of a web-based register for the Dutch national study on biologicals in JIA: www.ABC-register.nlF H M Prince, I S Ferket, S Kamphuis, et al.
Annals of the Rheumatic Diseases|June 16, 2009
When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritisF H M Prince, M Twilt, S C M Simon, et al.
Annals of the Rheumatic Diseases|July 8, 2009
Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritisF H M Prince, L M Geerdink, G J J M Borsboom, et al.
Pediatric Rheumatology Online Journal|February 8, 2017
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-studyP C E Hissink Muller, D M C Brinkman, D Schonenberg, et al.
Pediatric Rheumatology Online Journal|September 6, 2019
No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritisP C E Hissink Muller, W G van Braak, D Schreurs, et al.
Annals of the Rheumatic Diseases|July 23, 2013
Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patientsP C E Hissink Muller, J Anink, J Shi, et al.
Pageof 1